The Radiopharmaceutical Therapy and Dosimetry Lab at Johns Hopkins Medicine, headed by George Sgouros, Ph.D., has been awarded a $15 million grant, to be dispersed over the next five years, from the National Cancer Institute at the National Institutes of Health.
Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure
MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.